BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○
Discoveries/Similarity Discovery
TYPE 2X-VAULT TIMESTAMPED

Similarity Discovery

Compounds with highly similar target profiles that have not been studied together. Identifies pairs where shared biology implies shared mechanism.

METHOD · Jaccard similarity over binary target vectors. Pairs filtered by minimum overlap, divergent study counts, and distinct chemical identity.
SIGNAL · Two or more compounds converging on the same target set — one well-studied, one understudied — implying transferable mechanism hypotheses.
100 discoveriesX-Vault Merkle chain
ExploratoryEvidence CUnderstudied

FIMEPINOSTAT

Similarity bridge: fimepinostat ↔ azumamide_e via HDAC2, HDAC8, HDAC4 +7 more

30
/ 100
Novelty20
Target evidence11
Pathway relevance14
Literature gap17
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

FIMEPINOSTAT

Similarity bridge: fimepinostat ↔ abexinostat via HDAC2, HDAC8, HDAC4 +7 more

30
/ 100
Novelty20
Target evidence11
Pathway relevance14
Literature gap17
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

FIMEPINOSTAT

Similarity bridge: fimepinostat ↔ givinostat via HDAC2, HDAC8, HDAC4 +7 more

30
/ 100
Novelty20
Target evidence11
Pathway relevance14
Literature gap17
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

FIMEPINOSTAT

Similarity bridge: fimepinostat ↔ pracinostat via HDAC2, HDAC8, HDAC4 +7 more

30
/ 100
Novelty20
Target evidence11
Pathway relevance14
Literature gap17
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

FIMEPINOSTAT

Similarity bridge: fimepinostat ↔ nexturastat_a via HDAC2, HDAC8, HDAC4 +7 more

30
/ 100
Novelty20
Target evidence11
Pathway relevance14
Literature gap17
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

FIMEPINOSTAT

Similarity bridge: fimepinostat ↔ tubastatin_a via HDAC2, HDAC8, HDAC4 +7 more

30
/ 100
Novelty20
Target evidence11
Pathway relevance14
Literature gap17
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

FIMEPINOSTAT

Similarity bridge: fimepinostat ↔ romidepsin via HDAC2, HDAC8, HDAC4 +7 more

30
/ 100
Novelty21
Target evidence12
Pathway relevance15
Literature gap18
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

FIMEPINOSTAT

Similarity bridge: fimepinostat ↔ dacinostat via HDAC2, HDAC8, HDAC4 +7 more

30
/ 100
Novelty10
Target evidence14
Pathway relevance6
Literature gap20
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

FIMEPINOSTAT

Similarity bridge: fimepinostat ↔ quisinostat via HDAC2, HDAC8, HDAC4 +7 more

32
/ 100
Novelty12
Target evidence14
Pathway relevance9
Literature gap17
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

PF 03758309

Similarity bridge: pf_03758309 ↔ ruboxistaurin via AAK1, BMP2K, CAMK2D +7 more

24
/ 100
Novelty7
Target evidence13
Pathway relevance9
Literature gap13
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

PF 03758309

Similarity bridge: pf_03758309 ↔ pf_00562271 via PAK4, AURKA, AURKB +7 more

24
/ 100
Novelty8
Target evidence14
Pathway relevance10
Literature gap14
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

PF 03758309

Similarity bridge: pf_03758309 ↔ enzastaurin via PAK3, AAK1, BMP2K +7 more

24
/ 100
Novelty8
Target evidence14
Pathway relevance10
Literature gap14
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

PF 03758309

Similarity bridge: pf_03758309 ↔ midostaurin via PAK1, PAK3, PAK2 +7 more

24
/ 100
Novelty9
Target evidence8
Pathway relevance11
Literature gap15
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

PF 03758309

Similarity bridge: pf_03758309 ↔ nintedanib via PAK4, PAK5, PAK3 +7 more

24
/ 100
Novelty10
Target evidence9
Pathway relevance12
Literature gap16
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

PF 03758309

Similarity bridge: pf_03758309 ↔ ucn_01 via PAK4, PAK6, AAK1 +7 more

25
/ 100
Novelty12
Target evidence11
Pathway relevance13
Literature gap17
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

PF 03758309

Similarity bridge: pf_03758309 ↔ azd_7762 via PAK4, AAK1, ABL2 +7 more

25
/ 100
Novelty14
Target evidence13
Pathway relevance15
Literature gap19
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

PF 03758309

Similarity bridge: pf_03758309 ↔ pf_03814735 via PAK4, AAK1, AURKA +7 more

25
/ 100
Novelty15
Target evidence14
Pathway relevance5
Literature gap20
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

PF 03758309

Similarity bridge: pf_03758309 ↔ at_9283 via PAK4, PAK6, AAK1 +7 more

25
/ 100
Novelty15
Target evidence14
Pathway relevance5
Literature gap20
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

PF 03758309

Similarity bridge: pf_03758309 ↔ k_252a via PAK4, AAK1, AURKA +7 more

26
/ 100
Novelty18
Target evidence10
Pathway relevance8
Literature gap6
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

DACINOSTAT

Similarity bridge: dacinostat ↔ belinostat via HDAC1, HDAC2, HDAC3 +7 more

32
/ 100
Novelty12
Target evidence14
Pathway relevance9
Literature gap17
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

DACINOSTAT

Similarity bridge: dacinostat ↔ romidepsin via HDAC1, HDAC2, HDAC3 +7 more

32
/ 100
Novelty13
Target evidence15
Pathway relevance10
Literature gap18
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

DACINOSTAT

Similarity bridge: dacinostat ↔ tubacin via HDAC1, HDAC2, HDAC3 +7 more

32
/ 100
Novelty19
Target evidence14
Pathway relevance16
Literature gap7
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

DACINOSTAT

Similarity bridge: dacinostat ↔ entinostat via HDAC1, HDAC2, HDAC3 +7 more

32
/ 100
Novelty19
Target evidence14
Pathway relevance16
Literature gap7
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

DACINOSTAT

Similarity bridge: dacinostat ↔ azumamide_e via HDAC1, HDAC2, HDAC3 +7 more

33
/ 100
Novelty13
Target evidence15
Pathway relevance13
Literature gap14
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

DACINOSTAT

Similarity bridge: dacinostat ↔ abexinostat via HDAC1, HDAC2, HDAC3 +7 more

33
/ 100
Novelty13
Target evidence15
Pathway relevance13
Literature gap14
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

DACINOSTAT

Similarity bridge: dacinostat ↔ givinostat via HDAC1, HDAC2, HDAC3 +7 more

33
/ 100
Novelty13
Target evidence15
Pathway relevance13
Literature gap14
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

DACINOSTAT

Similarity bridge: dacinostat ↔ pracinostat via HDAC1, HDAC2, HDAC3 +7 more

33
/ 100
Novelty13
Target evidence15
Pathway relevance13
Literature gap14
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

DACINOSTAT

Similarity bridge: dacinostat ↔ nexturastat_a via HDAC1, HDAC2, HDAC3 +7 more

33
/ 100
Novelty13
Target evidence15
Pathway relevance13
Literature gap14
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

DACINOSTAT

Similarity bridge: dacinostat ↔ tubastatin_a via HDAC1, HDAC2, HDAC3 +7 more

33
/ 100
Novelty13
Target evidence15
Pathway relevance13
Literature gap14
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

FILGOTINIB

Similarity bridge: filgotinib ↔ bdb_us9663526_example_8_us10463675_example_8_us10980815_ex_no_8_us11197867_example_8 via JAK1, JAK2, TYK2 +1 more

22
/ 100
Novelty16
Target evidence9
Pathway relevance4
Literature gap8
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

FILGOTINIB

Similarity bridge: filgotinib ↔ bdb_us9663526_example_36_us10463675_example_36_us10980815_ex_no_36_us11197867_exampl via JAK1, JAK2, TYK2 +1 more

22
/ 100
Novelty16
Target evidence9
Pathway relevance4
Literature gap8
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

FILGOTINIB

Similarity bridge: filgotinib ↔ bdb_pf_02384554_us10966980_example_8_us9035074_8 via JAK1, JAK2, TYK2 +1 more

22
/ 100
Novelty16
Target evidence9
Pathway relevance4
Literature gap8
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

FILGOTINIB

Similarity bridge: filgotinib ↔ bdb_e_z_2_cyano_n_n_dimethyl_3_5_1_1s_2r_2_methylcyclohexyl_1_6_dihydroimidazo_4_5_d via JAK1, JAK2, TYK2 +1 more

22
/ 100
Novelty16
Target evidence9
Pathway relevance4
Literature gap8
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

FILGOTINIB

Similarity bridge: filgotinib ↔ bdb_chembl4446102 via JAK1, JAK2, TYK2 +1 more

22
/ 100
Novelty16
Target evidence9
Pathway relevance4
Literature gap8
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

FILGOTINIB

Similarity bridge: filgotinib ↔ bdb_chembl4238926 via JAK1, JAK2, TYK2 +1 more

22
/ 100
Novelty16
Target evidence9
Pathway relevance4
Literature gap8
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

FILGOTINIB

Similarity bridge: filgotinib ↔ bdb_asp_015k_asp015k_peficitinib via JAK1, JAK2, TYK2 +1 more

22
/ 100
Novelty16
Target evidence9
Pathway relevance4
Literature gap8
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

FILGOTINIB

Similarity bridge: filgotinib ↔ pacritinib via JAK1, JAK2, TYK2 +7 more

23
/ 100
Novelty17
Target evidence10
Pathway relevance6
Literature gap9
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

FILGOTINIB

Similarity bridge: filgotinib ↔ itacitinib via JAK1, JAK2, TYK2 +2 more

23
/ 100
Novelty19
Target evidence12
Pathway relevance8
Literature gap11
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

FILGOTINIB

Similarity bridge: filgotinib ↔ cerdulatinib via JAK1, JAK2, TYK2 +6 more

24
/ 100
Novelty8
Target evidence14
Pathway relevance10
Literature gap14
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

GF 109203

Similarity bridge: gf_109203 ↔ paullone via SIRT2, SIRT1, GSK3B

20
/ 100
Novelty9
Target evidence9
Pathway relevance9
Literature gap19
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

GF 109203

Similarity bridge: gf_109203 ↔ lgh_447 via PIM1, PRKCQ, GSK3B +1 more

21
/ 100
Novelty10
Target evidence10
Pathway relevance10
Literature gap3
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

GF 109203

Similarity bridge: gf_109203 ↔ bisindolylmaleimide_ix via PRKCA, PIM1, SIRT2 +3 more

21
/ 100
Novelty11
Target evidence11
Pathway relevance11
Literature gap4
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

GF 109203

Similarity bridge: gf_109203 ↔ sotrastaurin via PRKCA, PIM1, PRKCZ +7 more

24
/ 100
Novelty7
Target evidence13
Pathway relevance9
Literature gap13
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

NINTEDANIB

Similarity bridge: nintedanib ↔ pha_665752 via KDR, FGFR1, PDGFRA +7 more

29
/ 100
Novelty11
Target evidence15
Pathway relevance16
Literature gap7
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

NINTEDANIB

Similarity bridge: nintedanib ↔ r_406 via KDR, FGFR1, PDGFRA +7 more

29
/ 100
Novelty12
Target evidence16
Pathway relevance6
Literature gap8
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

NINTEDANIB

Similarity bridge: nintedanib ↔ midostaurin via KDR, FGFR1, PDGFRA +7 more

29
/ 100
Novelty13
Target evidence10
Pathway relevance7
Literature gap9
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

NINTEDANIB

Similarity bridge: nintedanib ↔ lestaurtinib via KDR, FGFR1, PDGFRA +7 more

30
/ 100
Novelty16
Target evidence14
Pathway relevance10
Literature gap13
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

NINTEDANIB

Similarity bridge: nintedanib ↔ dovitinib via KDR, FGFR1, PDGFRA +7 more

30
/ 100
Novelty17
Target evidence15
Pathway relevance11
Literature gap14
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

NINTEDANIB

Similarity bridge: nintedanib ↔ tozasertib via KDR, FGFR1, PDGFRA +7 more

30
/ 100
Novelty17
Target evidence15
Pathway relevance11
Literature gap14
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

NINTEDANIB

Similarity bridge: nintedanib ↔ tae_684 via KDR, FGFR1, PDGFRA +7 more

30
/ 100
Novelty18
Target evidence16
Pathway relevance12
Literature gap15
Coverage
0 studies
Timestamped
May 15, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

NINTEDANIB

Similarity bridge: nintedanib ↔ fedratinib via KDR, FGFR1, PDGFRA +7 more

30
/ 100
Novelty18
Target evidence16
Pathway relevance12
Literature gap15
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

NINTEDANIB

Similarity bridge: nintedanib ↔ kw_2449 via KDR, FGFR1, PDGFRA +7 more

31
/ 100
Novelty12
Target evidence16
Pathway relevance8
Literature gap5
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

NINTEDANIB

Similarity bridge: nintedanib ↔ su_014813 via KDR, FGFR1, PDGFRA +7 more

31
/ 100
Novelty14
Target evidence11
Pathway relevance10
Literature gap7
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

ABEMACICLIB

Similarity bridge: abemaciclib ↔ y_39983 via AAK1, BMP2K, CDK9 +7 more

22
/ 100
Novelty16
Target evidence9
Pathway relevance4
Literature gap8
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

ABEMACICLIB

Similarity bridge: abemaciclib ↔ enzastaurin via AAK1, BMP2K, CAMK2D +7 more

22
/ 100
Novelty16
Target evidence9
Pathway relevance4
Literature gap8
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

ABEMACICLIB

Similarity bridge: abemaciclib ↔ bms_387032 via CDK16, CDK2, CDK4 +7 more

23
/ 100
Novelty17
Target evidence10
Pathway relevance6
Literature gap9
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

ABEMACICLIB

Similarity bridge: abemaciclib ↔ momelotinib via AAK1, ADCK1, BMP2K +7 more

23
/ 100
Novelty18
Target evidence11
Pathway relevance7
Literature gap10
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

ABEMACICLIB

Similarity bridge: abemaciclib ↔ at_7519 via CAMKK2, CDK16, CDK2 +7 more

24
/ 100
Novelty7
Target evidence13
Pathway relevance9
Literature gap13
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

ABEMACICLIB

Similarity bridge: abemaciclib ↔ zotiraciclib via ADCK1, CDK16, CDK2 +7 more

24
/ 100
Novelty7
Target evidence13
Pathway relevance9
Literature gap13
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

ABEMACICLIB

Similarity bridge: abemaciclib ↔ palbociclib via AAK1, BMP2K, CAMK2D +7 more

24
/ 100
Novelty8
Target evidence14
Pathway relevance10
Literature gap14
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

ABEMACICLIB

Similarity bridge: abemaciclib ↔ rg_547 via CAMK2D, CAMK2G, CAMKK2 +7 more

24
/ 100
Novelty8
Target evidence14
Pathway relevance10
Literature gap14
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

ABEMACICLIB

Similarity bridge: abemaciclib ↔ silmitasertib via CDK16, CDK2, CLK1 +7 more

25
/ 100
Novelty15
Target evidence14
Pathway relevance5
Literature gap20
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

NILOTINIB

Similarity bridge: nilotinib ↔ vandetanib via ABL1, KIT, PDGFRA +7 more

24
/ 100
Novelty10
Target evidence9
Pathway relevance12
Literature gap16
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

NILOTINIB

Similarity bridge: nilotinib ↔ cep_32496 via RAF1, ABL1, KIT +7 more

24
/ 100
Novelty10
Target evidence9
Pathway relevance12
Literature gap16
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

NILOTINIB

Similarity bridge: nilotinib ↔ saracatinib via ABL1, KIT, PDGFRA +7 more

24
/ 100
Novelty10
Target evidence9
Pathway relevance12
Literature gap16
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

NILOTINIB

Similarity bridge: nilotinib ↔ neflamapimod via ABL1, PDGFRA, PDGFRB +7 more

25
/ 100
Novelty12
Target evidence11
Pathway relevance13
Literature gap17
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

NILOTINIB

Similarity bridge: nilotinib ↔ raf_265 via RAF1, ABL1, KIT +7 more

25
/ 100
Novelty13
Target evidence12
Pathway relevance14
Literature gap18
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

NILOTINIB

Similarity bridge: nilotinib ↔ bafetinib via ABL1, PDGFRB, DDR1 +7 more

25
/ 100
Novelty14
Target evidence13
Pathway relevance15
Literature gap19
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

NILOTINIB

Similarity bridge: nilotinib ↔ dasatinib_anhydrous via ABL1, KIT, DDR1 +7 more

26
/ 100
Novelty17
Target evidence9
Pathway relevance7
Literature gap5
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

NILOTINIB

Similarity bridge: nilotinib ↔ doramapimod via RAF1, ABL1, KIT +7 more

26
/ 100
Novelty19
Target evidence11
Pathway relevance9
Literature gap7
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

NILOTINIB

Similarity bridge: nilotinib ↔ imatinib via RAF1, CA1, CA2 +7 more

27
/ 100
Novelty11
Target evidence9
Pathway relevance14
Literature gap12
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

CERITINIB

Similarity bridge: ceritinib ↔ azd_1480 via FLT3, NTRK1, RET +7 more

22
/ 100
Novelty14
Target evidence14
Pathway relevance13
Literature gap6
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

CERITINIB

Similarity bridge: ceritinib ↔ ponatinib via KDR, FLT3, KIT +7 more

22
/ 100
Novelty15
Target evidence8
Pathway relevance14
Literature gap7
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

CERITINIB

Similarity bridge: ceritinib ↔ maleimide via KDR, FLT3, KIT +7 more

22
/ 100
Novelty15
Target evidence8
Pathway relevance14
Literature gap7
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

CERITINIB

Similarity bridge: ceritinib ↔ lorlatinib via NTRK1, JAK2, NTRK2 +7 more

22
/ 100
Novelty16
Target evidence9
Pathway relevance4
Literature gap8
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

CERITINIB

Similarity bridge: ceritinib ↔ rebastinib via KDR, FLT3, KIT +7 more

23
/ 100
Novelty18
Target evidence11
Pathway relevance7
Literature gap10
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

CERITINIB

Similarity bridge: ceritinib ↔ asp_3026 via FLT3, LCK, IGF1R +7 more

23
/ 100
Novelty18
Target evidence11
Pathway relevance7
Literature gap10
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

CERITINIB

Similarity bridge: ceritinib ↔ bms_754807 via FLT3, NTRK1, RET +7 more

23
/ 100
Novelty19
Target evidence12
Pathway relevance8
Literature gap11
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

CERITINIB

Similarity bridge: ceritinib ↔ entrectinib via FLT3, NTRK1, RET +7 more

24
/ 100
Novelty8
Target evidence14
Pathway relevance10
Literature gap14
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

CERITINIB

Similarity bridge: ceritinib ↔ brigatinib via KDR, FLT3, KIT +7 more

25
/ 100
Novelty12
Target evidence11
Pathway relevance13
Literature gap17
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

CERITINIB

Similarity bridge: ceritinib ↔ infigratinib via KDR, FLT3, KIT +7 more

25
/ 100
Novelty12
Target evidence11
Pathway relevance13
Literature gap17
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

PONATINIB

Similarity bridge: ponatinib ↔ dasatinib_anhydrous via ABL1, KIT, RET +7 more

25
/ 100
Novelty12
Target evidence11
Pathway relevance13
Literature gap17
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

PONATINIB

Similarity bridge: ponatinib ↔ golvatinib via ABL1, FLT3, KDR +7 more

25
/ 100
Novelty13
Target evidence12
Pathway relevance14
Literature gap18
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

PONATINIB

Similarity bridge: ponatinib ↔ vandetanib via ABL1, KIT, FLT3 +7 more

25
/ 100
Novelty13
Target evidence12
Pathway relevance14
Literature gap18
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

PONATINIB

Similarity bridge: ponatinib ↔ tivozanib via ABL1, KIT, FLT3 +7 more

25
/ 100
Novelty15
Target evidence14
Pathway relevance5
Literature gap20
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

PONATINIB

Similarity bridge: ponatinib ↔ doramapimod via ABL1, KIT, FLT3 +7 more

25
/ 100
Novelty15
Target evidence14
Pathway relevance5
Literature gap20
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

PONATINIB

Similarity bridge: ponatinib ↔ cep_32496 via ABL1, KIT, FLT3 +7 more

26
/ 100
Novelty16
Target evidence15
Pathway relevance6
Literature gap4
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

PONATINIB

Similarity bridge: ponatinib ↔ nilotinib via ABL1, KIT, FLT3 +7 more

26
/ 100
Novelty17
Target evidence9
Pathway relevance7
Literature gap5
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

PONATINIB

Similarity bridge: ponatinib ↔ saracatinib via ABL1, KIT, FLT3 +7 more

26
/ 100
Novelty17
Target evidence9
Pathway relevance7
Literature gap5
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

PONATINIB

Similarity bridge: ponatinib ↔ bafetinib via ABL1, RET, ABL2 +7 more

26
/ 100
Novelty18
Target evidence10
Pathway relevance8
Literature gap6
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

PONATINIB

Similarity bridge: ponatinib ↔ rebastinib via ABL1, KIT, FLT3 +7 more

27
/ 100
Novelty9
Target evidence14
Pathway relevance12
Literature gap10
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

BERBERINE CHLORIDE

Similarity bridge: berberine_chloride ↔ oxiconazole via ACHE, ADRA2B, ADRA2C +3 more

21
/ 100
Novelty11
Target evidence11
Pathway relevance11
Literature gap4
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

BERBERINE CHLORIDE

Similarity bridge: berberine_chloride ↔ latrepirdine via ACHE, ADRA2B, ADRA2C +3 more

22
/ 100
Novelty14
Target evidence14
Pathway relevance13
Literature gap6
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

BERBERINE CHLORIDE

Similarity bridge: berberine_chloride ↔ bambuterol via ACHE, CYP2D6, BCHE

22
/ 100
Novelty14
Target evidence14
Pathway relevance13
Literature gap6
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

BERBERINE CHLORIDE

Similarity bridge: berberine_chloride ↔ amisulpride via ACHE, ADRA2B, ADRA2C +2 more

23
/ 100
Novelty18
Target evidence11
Pathway relevance7
Literature gap10
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

IBRUTINIB

Similarity bridge: ibrutinib ↔ dasatinib_anhydrous via LYN, EGFR, RET +7 more

22
/ 100
Novelty16
Target evidence9
Pathway relevance4
Literature gap8
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

IBRUTINIB

Similarity bridge: ibrutinib ↔ canertinib via BTK, LYN, EGFR +7 more

22
/ 100
Novelty16
Target evidence9
Pathway relevance4
Literature gap8
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

IBRUTINIB

Similarity bridge: ibrutinib ↔ ponatinib via BTK, LYN, RET +7 more

22
/ 100
Novelty16
Target evidence9
Pathway relevance4
Literature gap8
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

IBRUTINIB

Similarity bridge: ibrutinib ↔ tirabrutinib via BTK, BLK, BMX +6 more

22
/ 100
Novelty16
Target evidence9
Pathway relevance4
Literature gap8
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →
ExploratoryEvidence CUnderstudied

IBRUTINIB

Similarity bridge: ibrutinib ↔ cabozantinib via LYN, EGFR, RET +7 more

23
/ 100
Novelty18
Target evidence11
Pathway relevance7
Literature gap10
Coverage
0 studies
Timestamped
May 14, 2026
✓X-Vault sealed
REPORT CONTENTS
→Full mechanism hypothesis
→Complete target mapping
→Pathway network analysis
→Supporting literature PMIDs
View Hypothesis →

All outputs are computational hypothesis candidates — not experimentally validated discoveries. Deterministic graph analysis · X-Vault cryptographic timestamping · Organiq Sweden AB · Patent pending: EVE-PAT-2026-001